KIMBERLY GO: Open Payments
NPI 1912919036 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 15 payments from 7 companies in 2025. Trend: 2023 $433 · 2024 $564 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $108 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $22 |
Products named: Repatha, LEQVIO, CAMZYOS, NEXLETOL, JOURNAVX, Kerendia, Rybelsus.
Industry payments across NY — which companies pay providers there.
